Abstract:Background: Gastric cancer (GC) is the fifth most common malignant tumor and the third leading cause of cancer-related deaths worldwide. Neutrophil extracellular traps (NETs) can enhance the invasion of GC cells and are associated with poor prognosis in patients. However, its mechanism of action is not completely understood. Methods: The content of NETs in the peripheral blood of patients with GC was detected by enzyme-linked immunosorbent assay. GC AGS cells were treated with or without NETs for 24 h. High-throughput RNA sequencing was performed to screen differentially expressed long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs). Real-time polymerase chain reaction (PCR) was used to verify gene expression. A competing endogenous RNA (ceRNA) regulatory network was constructed. Modules were screened using the molecular complex detection (MCODE) plug-in. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed using the genes in the network. The role and clinical significance of the lncRNA NEAT1 -related signaling pathway were validated. Results: The content of NETs in the patients with GC was significantly higher than that in healthy controls and was also higher in patients with high-grade (stages III and IV) GC. NETs promoted the invasion of AGS cells. A total of 1,340 lncRNAs, 315 miRNAs, and 1,083 mRNAs were differentially expressed after NET treatment. The expression of five genes was validated using real-time PCR, which were in accordance with the RNA sequencing results. A ceRNA regulatory network was constructed with 1,239 lncRNAs, 310 miRNAs, and 1,009 mRNAs. Four genes ( RAB3B , EPB41L4B , ABCB11 , and CCDC88A ) in the ceRNA network were associated with patient prognosis, with RAB3B being the most prominent and with signaling among the lncRNA NEAT1 , the miRNA miR-3158-5p, and RAB3B . NEAT1 was upregulated in AGS cells after NET treatment. RNA interference of NEAT1 inhibited the invasion of AGS cells induced by NETs, inhibited miR-3158-5p expression, and promoted RAB3B expression. NEAT1 and RAB3B expression were positively correlated in patients with GC. Furthermore, RAB3B was upregulated and miR-3158-5p was downregulated in GC tissues compared with adjacent normal tissues, which was also associated with cancer stage. Conclusion: This study provides a comprehensive analysis of differentially expressed genes in NET-treated GC cells and validated the clinical significance of NEAT1 -related signaling.

Aberrant Neat1 Expression is Associated with Clinical Outcome in High Grade Glioma Patients

Relationship of expression level of long non-coding RNA NEAT1 with prognoses in the patients with gliomas

Long Non-Coding RNA NEAT1 Overexpression is Associated with Poor Prognosis in Cancer Patients: a Systematic Review and Meta-Analysis

Neat Expression Is Associated With Tumor Recurrence And Unfavorable Prognosis In Colorectal Cancer

Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.

A Meta-Analysis of the Prognostic Value of Abnormally Expressed Lncrnas and Correlation with Clinicopathological Characteristics in Glioma

Meta-analysis of the Correlation Between High Expression of lncRNA NEAT1 in Rectal Cancer and Pathological Features and Prognosis

Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway

Aberrant NEAT 1 promotes migration in endometrial cancer and as marker of poor prognosis

Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma

The Clinical Value of Lncrna NEAT1 in Digestive System Malignancies: A Comprehensive Investigation Based on 57 Microarray and RNA-seq Datasets

Long Non-Coding RNA NEAT1 Overexpression is Associated with Unfavorable Prognosis in Patients with Hepatocellular Carcinoma after Hepatectomy: A Chinese Population-Based Study

Pan-cancer analysis of long non-coding RNA NEAT1 in various cancers

Figure S1-8 from Long Noncoding RNA <i>neat1</i>, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/<b>β</b>-Catenin Pathway by Scaffolding EZH2

Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis

Lncrna NEAT1 Promotes Colorectal Cancer Progression by Increasing Inflammation

LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.

Nuclear-enriched Abundant Transcript 1 As a Diagnostic and Prognostic Biomarker in Colorectal Cancer

Enhanced Expression of Long Non-Coding RNA NEAT1 is Associated with the Progression of Gastric Adenocarcinomas

Comprehensive Expression Profile Analysis of Neutrophil Extracellular Trap-Affected Genes in Gastric Cancer Cells and the Clinical Significance of lncRNA NEAT1-Related Signaling

LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis